Royal Bank Of Canada Kempharm, Inc Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Kempharm, Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 4,904 shares of KMPH stock, worth $24,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,904
Previous 5,426
9.62%
Holding current value
$24,225
Previous $26,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KMPH
# of Institutions
115Shares Held
30.2MCall Options Held
284KPut Options Held
24.1K-
Woodline Partners LP San Francisco, CA4.14MShares$20.4 Million0.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$18 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.34MShares$11.6 Million0.58% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...